The possible influence of the COVID-19 pandemic on the fluctuation in the number of HPV infection cases in Brazil
DOI:
https://doi.org/10.33448/rsd-v13i1.44526Keywords:
HPV; Pandemic; Vaccination; COVID-19.Abstract
The article aims to highlight the influence of the COVID-19 pandemic on the fluctuation of HPV infection cases in Brazil. Emphasizing the pandemic as a global challenge, it underscores the spread of SARS-CoV-2 and its impact on public health. It relates the pandemic to the decline in vaccination campaigns, including the HPV vaccine. Qualitative and quantitative examination of documents related to the subject was sought, collected from secondary sources such as Pubmed, Scientific Electronic Library Online (SciELO), and DATASUS. The results indicate the impacts of COVID-19, highlighting the lack of coordination in the Brazilian response, the interruption of routine medical services, and the decrease in vaccination rates. The work emphasizes that HPV experienced a decline in vaccine coverage between 2019 and 2022. It can be concluded that there was a significant repercussion of the health crisis on immunization strategies, demonstrating a reduction in vaccine coverage and an increase in the anti-vaccine movement. The relationship between the decline in immunization and the increase in HPV infection cases, especially after the pandemic, raises concerns about the possible rise in cervical cancer cases associated with low vaccine coverage.
References
Ali, I. (2020). Impact of COVID-19 on vaccination programs: adverse or positive? Human vaccines & immunotherapeutics, 16(11), 2594-2600.
Almeida, R. C. A. A., de Castro, J. M., de Castro Oliveira, T. V., de Oliveira, T. F., Araújo, D. A., Azevedo, M. A., & Costa, W. J. T. (2020). Cobertura vacinal ANTI-HPV e motivos de não vacinação. Revista Eletrônica Acervo Enfermagem, 2, e2600-e2600.
Brasil, M. S. (2014). Guia prático sobre o HPV: perguntas e respostas para profissionais de saúde. Cartilha profissionais de saúde. Brasília.
Brasil, M. S. (2023). Queda da cobertura vacinal contra o HPV representa risco de aumento de casos de cânceres evitáveis no Brasil.
Brasil, M. S. (2022). Queda nas taxas de vacinação no Brasil ameaça a saúde das crianças. Instituto Butantan. https://butantan.gov.br/noticias/queda-nas-taxas-de-vacinacao-no-brasil-ameaca-a-saude-das-criancas
Brasil M. S. (2023). Queda da cobertura vacinal contra o HPV representa risco de aumento de casos de cânceres evitáveis no Brasil https://www.gov.br/saude/pt-br/assuntos/noticias/2023/fevereiro/queda-da-cobertura-vacinal-contra-o-hpv-representa-risco-de-aumento-de-casos-de-canceres-evitaveis-no-brasil#:~:text=Em%202019%2C%2087%2C08%25,52%2C16%25%20em%202022.
Bueno, F. T. C., Souto, E. P., & Matta, G. C. (2021). Notas sobre a Trajetória da Covid-19 no Brasil. Book: Os impactos sociais da COVID-19 no Brasil: populações vulnerabilizadas e respostas à pandemia. Organizer: Matta GC, Rego S, Souto E, Segata J. Publisher: FioCruz, 1, 27-40.
Castañeda Gullot, C., & Ramos Serpa, G. (2020). Principales pandemias en la historia de la humanidad. Revista cubana de Pediatría, 92.
Cavalcante, R. L. Damasceno, H. C., da Silva Júnior, A. F., & Pinheiro, M. D. C. N. (2021). Impacto da pandemia por COVID-19 na imunização da vacina contra o Papilomavírus Humano entre crianças e adolescentes de 9 a 14 anos na região do Xingu-Pará. Research, Society and Development, 10(4), e36310413987-e36310413987.
Cruz, A. (2017). A queda da imunização no Brasil. Revista Consensus, 7(3), 20-9.
Matos, C. C. D. S. A., Barbieri, C. L. A., & Couto, M. T. (2020). Covid-19 and its impact on immunization programs: reflections from Brazil. Revista de Saúde Pública, 54.
Mattos, P. C. (2015). Tipos de revisão de literatura. Unesp, 1-9.
Mello, C. F. (2013). Vacinação contra papilomavírus humano. Einstein, 11, 547-549.
Mondiale de la Santé, O., & World Health Organization. (2022). Human papillomavirus vaccines: WHO position paper (2022 update)–Vaccins contre les papillomavirus humains: note de synthèse de l’OMS (mise à jour de 2022). Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire, 97(50), 645-672.
Moura, L. D. L., Codeço, C. T., & Luz, P. M. (2020). Cobertura da vacina papilomavírus humano (HPV) no Brasil: heterogeneidade espacial e entre coortes etárias. Revista brasileira de epidemiologia, 24.
Ota, M. O., Badur, S., Romano-Mazzotti, L., & Friedland, L. R. (2021). Impact of COVID-19 pandemic on routine immunization. Annals of Medicine, 53(1), 2286-2297.
Santos, J. G. C., & Dias, J. M. G. (2018). Vacinação pública contra o papilomavirus humano no Brasil. Rev Med Minas Gerais, 28(1), 1-7.
Sharma, A., Ahmad Farouk, I., & Lal, S. K. (2021). COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses, 13(2), 202.
Silva, T. M. R. D., Nogueira de Sá, A. C. M. G., Beinner, M. A., Abreu, M. N. S., Matozinhos, F. P., Sato, A. P. S., & Vieira, E. W. R. (2022). Impact of the COVID-19 pandemic on human papillomavirus vaccination in Brazil. International journal of public health, 67, 1604224.
Werneck, G. L., & Carvalho, M. S. (2020). A pandemia de COVID-19 no Brasil: crônica de uma crise sanitária anunciada. Cadernos de Saúde Pública, 36, e00068820.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sophia Lins de Lima; Anna Karolina Conceição do Amor Divino; Thamires Mascarenhas Silva; Vinicius Mendes Souza Carneiro
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
